NJF Capital is the venture investment arm of NJF Holdings, the private investment group founded by Nicole Junkermann.
Based in London, it invests internationally in companies developing transformative technologies across healthtech, deep tech, and the future of human performance.
As part of NJF Holdings – which also includes NJF Private Equity, NJF Real Estate, and NJF Sports & Media – NJF Capital focuses on ventures with the potential to scale globally and deliver lasting impact.
We invest where science meets purpose and where innovation meets consequence.
Life Sciences and Health Innovation
Investing in breakthrough biology, precision medicine, computational drug discovery, and health platforms that extend longevity and improve population-level outcomes.
Intelligent Systems and Advanced Computing
Backing frontier AI, autonomous technologies, secure compute, quantum research, and data infrastructure that underpins the next era of innovation.
Frontier Technologies and Applied Science
Supporting emerging technologies at the edge of science – from novel materials to bio-data convergence – with the potential to reshape industries and strengthen societal resilience.
